$ABBV Company News Investors warm up to Gilead's
Post# of 94270
Posted On: 01/13/2014 10:29:22 AM
$ABBV Company News
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Enanta's run continues up through the close; shares jump 28% 6:01 p.m. Dec. 10, 2013 - Russ Britt
More success for hepatitis C drug means a surge for Enanta shares 1:42 p.m. Dec. 10, 2013 - Russ Britt
Tesla cleared in German probe; Apple up on UBS upgrade 4:56 p.m. Dec. 3, 2013 - Sue Chang
FDA approving drugs faster, and it may stay that way, report says 6:10 p.m. Nov. 18, 2013 - Russ Britt
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Mixed bag of earnings ends up badly for two health-care firms 10:22 a.m. Oct. 25, 2013 - Russ Britt
Microsoft, Amazon, Zynga are stocks to watch 4:31 a.m. Oct. 25, 2013 - Sue Chang
FDA recommends new limits on pain drugs 10:25 p.m. Oct. 24, 2013 - Thomas M. Burton
Abbott Labs sets a brisk earnings pace by beating income forecasts 10:43 a.m. Oct. 16, 2013 - Russ Britt
AbbVie net falls 16% on separation costs 8:58 a.m. July 26, 2013 - MarketWatch.com
4 things traders should know for the next 24 hours 4:46 p.m. July 25, 2013 - blogs.marketwatch.com
The Next 24: Starbucks Surges 4:13 p.m. July 25, 2013 - MarketWatch
Pharmacyclics seeks fast-track drug approval, makes double-digit gain 10:09 a.m. July 10, 2013 - Russ Britt
European regulators set precedent with approval of new copycat drugs 2:04 p.m. June 28, 2013 - Russ Britt
No rest for the weary, or even the savvy, in Wall Street carnage 4:21 p.m. June 20, 2013 - Russ Britt
Supreme Court satisfies few with ruling on generic drug settlements 4:30 p.m. June 18, 2013 - Russ Britt
Dan Loeb's cheap stock picks 11:39 a.m. June 18, 2013 - Insider Monkey
Pacts that delay sale of generics in jeopardy 1:55 a.m. June 18, 2013 - Brent Kendall
Supreme Court decision on generics hits Actavis, but few other drug firms 11:46 a.m. June 17, 2013 - Russ Britt
Dividend Watch: 5 Stocks Going Ex-Dividend Monday: SBR, DSM, EAD, VTA, ABBV 10:00 a.m. Jan. 10, 2014 - TheStreet.com
Seattle Gentics-AbbVie Deal Expanded - Analyst Blog 5:10 p.m. Jan. 9, 2014 - Zacks.com
Seattle Genetics deepens collaboration with AbbVie 9:36 a.m. Jan. 8, 2014 - Seeking Alpha
Enanta Joins Big Leagues With Hepatitis C Drug 6:15 p.m. Jan. 7, 2014 - Investors Business Daily
Celgene's Stock Should See New All-Time Highs Due To Strong Pipeline 2:14 p.m. Jan. 3, 2014 - Seeking Alpha
The Perfect Portfolio: End Of Year Review 4:28 a.m. Jan. 1, 2014 - Seeking Alpha
BofA lifts target on AbbVie 2:27 p.m. Dec. 31, 2013 - Seeking Alpha
BofA Merrill Lynch Reiterates on AbbVie, Raises PO 9:03 a.m. Dec. 31, 2013 - benzinga.com
Many Key Changes to Goldman Sachs Conviction Buy List for 2014 10:52 a.m. Dec. 30, 2013 - 247WallSt.com
Co-Pays: Skin In The Game If It Ain't Your Skin? 1:33 p.m. Dec. 27, 2013 - Seeking Alpha
Pipeline Update on Santarus Candidate - Analyst Blog 5:10 p.m. Dec. 26, 2013 - Zacks.com
Drugmaker Aptalis Files For IPO After Overhaul 10:50 a.m. Dec. 26, 2013 - Investors Business Daily
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
Pipeline Progress at Novartis - Analyst Blog 5:42 p.m. Dec. 23, 2013 - Zacks.com
CHMP Positive on Roche's RoActemra's Subcutaneous Formulation - Analyst Blog 11:50 a.m. Dec. 23, 2013 - Zacks.com
Sandoz starts late stage study of Humira biosimilar 3:32 p.m. Dec. 19, 2013 - Seeking Alpha
Healthcare upgrades, downgrades, and initiations for Thursday 9:46 a.m. Dec. 19, 2013 - Seeking Alpha
S&P Stocks Hitting New Highs 4:33 p.m. Dec. 18, 2013 - FOXBusiness
ABBV Dividend Yield Pushes Past 3% 3:09 p.m. Dec. 18, 2013 - TheStreet.com
Gilead's Next Hepatitis C Drug A Hit In Trials 11:32 a.m. Dec. 18, 2013 - Investors Business Daily
Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with AbbVie 8:59 a.m. Jan. 8, 2014 - BusinessWire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Conference Calls, Regulatory Filings, and Member Enrollment - Research Report on UnitedHealth Group, AbbVie, Lilly, Actavis, and Humana 8:00 a.m. Jan. 6, 2014 - PR Newswire
Foundation for the NIH Announces First Results of I-SPY 2 Breast Cancer Clinical Trial 1:50 p.m. Dec. 26, 2013 - PR Newswire
Stock Price Movements, FDA Approvals, and Completed Acquisitions - Research Report on AbbVie, Baxter, IDEXX, Kythera Biopharmaceuticals, and Medical Properties Trust 8:00 a.m. Dec. 24, 2013 - PR Newswire
AbbVie to Present at 32nd Annual J.P. Morgan Healthcare Conference 1:00 p.m. Dec. 20, 2013 - PR Newswire
Critical Alerts For First Solar, Viacom, Lowe's, Vertex Pharmaceuticals, and AbbVie Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Dividends, Regulatory Filings, Merger Agreement, Quarterly Results Schedules, and Share Repurchase Programs - Research Report on AbbVie, Baxter, Cooper, ViroPharma, and Varian Medical Systems 8:05 a.m. Dec. 18, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
AbbVie Declares Quarterly Dividend 12:09 p.m. Dec. 12, 2013 - PR Newswire
Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision 8:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C 8:00 a.m. Dec. 10, 2013 - PR Newswire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
AbbVie Partners with HIV Community to Launch International Awareness Campaign Focused on Women Living with HIV 9:21 a.m. Nov. 26, 2013 - PR Newswire
Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories 8:00 a.m. Nov. 22, 2013 - PR Newswire
Federal Legislation Support, Philanthropic Activities, and Patent Challenges - Research Report on Mylan, Abbott, Actavis, AbbVie, and Agilent Technologies 8:00 a.m. Nov. 19, 2013 - PR Newswire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
AbbVie to Present at Jefferies 2013 Healthcare Conference 8:15 a.m. Nov. 14, 2013 - PR Newswire
Critical Alerts For Johnson and Johnson, AbbVie, Air Products and Chemicals, American Capital, and AFLAC Released By InvestorsObserver 9:31 a.m. Nov. 13, 2013 - PR Newswire
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Enanta's run continues up through the close; shares jump 28% 6:01 p.m. Dec. 10, 2013 - Russ Britt
More success for hepatitis C drug means a surge for Enanta shares 1:42 p.m. Dec. 10, 2013 - Russ Britt
Tesla cleared in German probe; Apple up on UBS upgrade 4:56 p.m. Dec. 3, 2013 - Sue Chang
FDA approving drugs faster, and it may stay that way, report says 6:10 p.m. Nov. 18, 2013 - Russ Britt
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Mixed bag of earnings ends up badly for two health-care firms 10:22 a.m. Oct. 25, 2013 - Russ Britt
Microsoft, Amazon, Zynga are stocks to watch 4:31 a.m. Oct. 25, 2013 - Sue Chang
FDA recommends new limits on pain drugs 10:25 p.m. Oct. 24, 2013 - Thomas M. Burton
Abbott Labs sets a brisk earnings pace by beating income forecasts 10:43 a.m. Oct. 16, 2013 - Russ Britt
AbbVie net falls 16% on separation costs 8:58 a.m. July 26, 2013 - MarketWatch.com
4 things traders should know for the next 24 hours 4:46 p.m. July 25, 2013 - blogs.marketwatch.com
The Next 24: Starbucks Surges 4:13 p.m. July 25, 2013 - MarketWatch
Pharmacyclics seeks fast-track drug approval, makes double-digit gain 10:09 a.m. July 10, 2013 - Russ Britt
European regulators set precedent with approval of new copycat drugs 2:04 p.m. June 28, 2013 - Russ Britt
No rest for the weary, or even the savvy, in Wall Street carnage 4:21 p.m. June 20, 2013 - Russ Britt
Supreme Court satisfies few with ruling on generic drug settlements 4:30 p.m. June 18, 2013 - Russ Britt
Dan Loeb's cheap stock picks 11:39 a.m. June 18, 2013 - Insider Monkey
Pacts that delay sale of generics in jeopardy 1:55 a.m. June 18, 2013 - Brent Kendall
Supreme Court decision on generics hits Actavis, but few other drug firms 11:46 a.m. June 17, 2013 - Russ Britt
Dividend Watch: 5 Stocks Going Ex-Dividend Monday: SBR, DSM, EAD, VTA, ABBV 10:00 a.m. Jan. 10, 2014 - TheStreet.com
Seattle Gentics-AbbVie Deal Expanded - Analyst Blog 5:10 p.m. Jan. 9, 2014 - Zacks.com
Seattle Genetics deepens collaboration with AbbVie 9:36 a.m. Jan. 8, 2014 - Seeking Alpha
Enanta Joins Big Leagues With Hepatitis C Drug 6:15 p.m. Jan. 7, 2014 - Investors Business Daily
Celgene's Stock Should See New All-Time Highs Due To Strong Pipeline 2:14 p.m. Jan. 3, 2014 - Seeking Alpha
The Perfect Portfolio: End Of Year Review 4:28 a.m. Jan. 1, 2014 - Seeking Alpha
BofA lifts target on AbbVie 2:27 p.m. Dec. 31, 2013 - Seeking Alpha
BofA Merrill Lynch Reiterates on AbbVie, Raises PO 9:03 a.m. Dec. 31, 2013 - benzinga.com
Many Key Changes to Goldman Sachs Conviction Buy List for 2014 10:52 a.m. Dec. 30, 2013 - 247WallSt.com
Co-Pays: Skin In The Game If It Ain't Your Skin? 1:33 p.m. Dec. 27, 2013 - Seeking Alpha
Pipeline Update on Santarus Candidate - Analyst Blog 5:10 p.m. Dec. 26, 2013 - Zacks.com
Drugmaker Aptalis Files For IPO After Overhaul 10:50 a.m. Dec. 26, 2013 - Investors Business Daily
Big Pharma Stocks: Year in Review 6:00 a.m. Dec. 24, 2013 - TheStreet.com
Pipeline Progress at Novartis - Analyst Blog 5:42 p.m. Dec. 23, 2013 - Zacks.com
CHMP Positive on Roche's RoActemra's Subcutaneous Formulation - Analyst Blog 11:50 a.m. Dec. 23, 2013 - Zacks.com
Sandoz starts late stage study of Humira biosimilar 3:32 p.m. Dec. 19, 2013 - Seeking Alpha
Healthcare upgrades, downgrades, and initiations for Thursday 9:46 a.m. Dec. 19, 2013 - Seeking Alpha
S&P Stocks Hitting New Highs 4:33 p.m. Dec. 18, 2013 - FOXBusiness
ABBV Dividend Yield Pushes Past 3% 3:09 p.m. Dec. 18, 2013 - TheStreet.com
Gilead's Next Hepatitis C Drug A Hit In Trials 11:32 a.m. Dec. 18, 2013 - Investors Business Daily
Seattle Genetics Further Expands Antibody-Drug Conjugate Collaboration with AbbVie 8:59 a.m. Jan. 8, 2014 - BusinessWire
Health Care Sector Under the Lens: Pfizer, Merck & Co., AbbVie and Zogenix 8:00 a.m. Jan. 8, 2014 - PR Newswire
Conference Calls, Regulatory Filings, and Member Enrollment - Research Report on UnitedHealth Group, AbbVie, Lilly, Actavis, and Humana 8:00 a.m. Jan. 6, 2014 - PR Newswire
Foundation for the NIH Announces First Results of I-SPY 2 Breast Cancer Clinical Trial 1:50 p.m. Dec. 26, 2013 - PR Newswire
Stock Price Movements, FDA Approvals, and Completed Acquisitions - Research Report on AbbVie, Baxter, IDEXX, Kythera Biopharmaceuticals, and Medical Properties Trust 8:00 a.m. Dec. 24, 2013 - PR Newswire
AbbVie to Present at 32nd Annual J.P. Morgan Healthcare Conference 1:00 p.m. Dec. 20, 2013 - PR Newswire
Critical Alerts For First Solar, Viacom, Lowe's, Vertex Pharmaceuticals, and AbbVie Released By InvestorsObserver 9:31 a.m. Dec. 19, 2013 - PR Newswire
Dividends, Regulatory Filings, Merger Agreement, Quarterly Results Schedules, and Share Repurchase Programs - Research Report on AbbVie, Baxter, Cooper, ViroPharma, and Varian Medical Systems 8:05 a.m. Dec. 18, 2013 - PR Newswire
Clinical Trial Results, Share Repurchase Transactions, Stock Price Updates, Appointments, and Investments - Research Report on AbbVie, Express Scripts, Actavis, Bristol-Myers Squibb, and GSK 8:00 a.m. Dec. 13, 2013 - PR Newswire
AbbVie Declares Quarterly Dividend 12:09 p.m. Dec. 12, 2013 - PR Newswire
Stock Price Updates - Research Report on AbbVie, Covance, MannKind, MAKO Surgical, and Envision 8:00 a.m. Dec. 11, 2013 - PR Newswire
Pharma Industry Morning Assessment: Pfizer, Merck & Co., AbbVie, and Zogenix 12:19 p.m. Dec. 10, 2013 - PR Newswire
AbbVie Demonstrates 96 percent SVR(12) in its Phase III Study of Treatment-Experienced Patients with Genotype 1 Hepatitis C 8:00 a.m. Dec. 10, 2013 - PR Newswire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
AbbVie Partners with HIV Community to Launch International Awareness Campaign Focused on Women Living with HIV 9:21 a.m. Nov. 26, 2013 - PR Newswire
Grants and Stock Movements of Major Drug Manufacturers - Research Report on AbbVie, Keryx Biopharmaceuticals, Pacira Pharmaceuticals, Rockwell Medical, and Impax Laboratories 8:00 a.m. Nov. 22, 2013 - PR Newswire
Federal Legislation Support, Philanthropic Activities, and Patent Challenges - Research Report on Mylan, Abbott, Actavis, AbbVie, and Agilent Technologies 8:00 a.m. Nov. 19, 2013 - PR Newswire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
AbbVie to Present at Jefferies 2013 Healthcare Conference 8:15 a.m. Nov. 14, 2013 - PR Newswire
Critical Alerts For Johnson and Johnson, AbbVie, Air Products and Chemicals, American Capital, and AFLAC Released By InvestorsObserver 9:31 a.m. Nov. 13, 2013 - PR Newswire
(0)
(0)